Detalhe da pesquisa
1.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Blood
; 142(23): 1960-1971, 2023 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647654
2.
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia.
Br J Haematol
; 192(6): 1026-1030, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32458446
3.
BET inhibitor resistance emerges from leukaemia stem cells.
Nature
; 525(7570): 538-42, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26367796
4.
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.
Blood
; 129(12): 1685-1690, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126926
5.
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.
Blood
; 129(21): 2882-2895, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283481
6.
Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.
Br J Haematol
; 191(1): 123-126, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648276
7.
Epigenetics in the hematologic malignancies.
Haematologica
; 99(12): 1772-83, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472952
8.
Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study.
Leuk Res
; 140: 107480, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499457
9.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
Blood Cancer J
; 14(1): 54, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531863
10.
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.
Leukemia
; 37(5): 1092-1102, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906715
11.
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Leuk Res
; 112: 106748, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34798569
12.
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Leuk Res
; 113: 106786, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063283
13.
An unusual case of microangiopathic hemolytic anemia resulting from metastatic angiosarcoma.
Blood
; 122(1): 7, 2013 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23984448
14.
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.
J Clin Oncol
; 38(30): 3506-3517, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687450
15.
Parvovirus B19induced pure red cell aplasia in a heart transplant recipient.
Blood
; 120(17): 3395, 2012 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23256205
16.
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Leukemia
; 38(2): 389-392, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263433
17.
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic.
Leuk Lymphoma
; 63(11): 2731-2734, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727162
18.
Functional interdependence of BRD4 and DOT1L in MLL leukemia.
Nat Struct Mol Biol
; 23(7): 673-81, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27294782
19.
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
Leuk Lymphoma
; 54(2): 336-41, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22812445